Chemed Ebitda from 2010 to 2026

CXM Stock  EUR 358.00  12.00  3.47%   
Chemed's EBITDA is increasing over the last several years with slightly volatile swings. EBITDA is predicted to flatten to about 368.7 M. During the period from 2010 to 2026 Chemed EBITDA regressed destribution of quarterly values had coefficient of variationof  44.72 and r-value of  0.88. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
452.5 M
Current Value
368.7 M
Quarterly Volatility
124.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Chemed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemed's main balance sheet or income statement drivers, such as Interest Expense of 2.3 M, Selling General Administrative of 352.2 M or Total Revenue of 2.2 B, as well as many indicators such as . Chemed financial statements analysis is a perfect complement when working with Chemed Valuation or Volatility modules.
  
This module can also supplement various Chemed Technical models . Check out the analysis of Chemed Correlation against competitors.
The Ebitda trend for Chemed offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Chemed is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Chemed's Ebitda Growth Pattern

Below is the plot of the Ebitda of Chemed over the last few years. It is Chemed's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemed's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Chemed Ebitda Regression Statistics

Arithmetic Mean277,467,791
Geometric Mean250,771,429
Coefficient Of Variation44.72
Mean Deviation113,556,509
Median283,453,000
Standard Deviation124,076,368
Sample Variance15394.9T
Range298.1M
R-Value0.88
Mean Square Error3686.9T
R-Squared0.78
Slope21,637,388
Total Sum of Squares246319.1T

Chemed Ebitda History

2026368.7 M
2025452.5 M
2022393.4 M
2021411.2 M
2020454.9 M
2019311.3 M
2018283.5 M

About Chemed Financial Statements

Chemed stakeholders use historical fundamental indicators, such as Chemed's Ebitda, to determine how well the company is positioned to perform in the future. Although Chemed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemed's assets and liabilities are reflected in the revenues and expenses on Chemed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA452.5 M368.7 M

Currently Active Assets on Macroaxis

Other Information on Investing in Chemed Stock

Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.